BioSig Technologies Inc (BSGM) Upgraded by Zacks Investment Research to “Hold”
BioSig Technologies Inc (NASDAQ:BSGM) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday.
According to Zacks, “BioSig Technologies, Inc. is a medical device company which is engaged in developing technology platform to improve cardiac recording during electrophysiology studies and ablation procedures. BioSig Technologies, Inc. is headquartered in Minnesota. “
Shares of BioSig Technologies (NASDAQ:BSGM) remained flat at $1.40 during mid-day trading on Tuesday. The company had a trading volume of 10,062 shares. The stock has a 50 day moving average price of $1.39 and a 200-day moving average price of $1.52. The firm’s market cap is $28.67 million. BioSig Technologies has a one year low of $0.90 and a one year high of $2.20.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/biosig-technologies-inc-bsgm-upgraded-by-zacks-investment-research-to-hold.html
BioSig Technologies Company Profile
BioSig Technologies, Inc is a development-stage medical device company. The Company is developing a technology platform to manage noise and artifacts from cardiac recordings during electrophysiology studies and ablation. It is engaged in developing the Precise Uninterrupted Real-time evaluation of Electrograms (PURE) electro-pneumatic (EP) System.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for BioSig Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.